cysteine and head activator peptide

cysteine has been researched along with head activator peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caltabiano, G; Ciruela, F; Fernández-Dueñas, V; Gandía, J; González-Muñiz, R; Morató, X; Pardo, L; Stagljar, I	1

Other Studies

1 other study(ies) available for cysteine and head activator peptide

Article	Year
The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain. Journal of neurochemistry, 2013, Volume: 125, Issue:3 Topics: Activating Transcription Factor 4; Analysis of Variance; Antibodies; Biotinylation; Calcium; Caspase 3; Cell Line, Transformed; Cell Survival; Cyclic AMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Intracellular Fluid; Mutation; Neuropeptides; Protein Structure, Tertiary; Protein Transport; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Thapsigargin; Transfection	2013

Article

Year

The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain.

Journal of neurochemistry, 2013, Volume: 125, Issue:3

Topics: Activating Transcription Factor 4; Analysis of Variance; Antibodies; Biotinylation; Calcium; Caspase 3; Cell Line, Transformed; Cell Survival; Cyclic AMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Intracellular Fluid; Mutation; Neuropeptides; Protein Structure, Tertiary; Protein Transport; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Thapsigargin; Transfection

2013